在三阴性乳腺癌中建模转移性免疫微环境
Laura Rodriguez de la Fuente1,2,3, Andrew M K Law3, Laura Rangel-Sanchez1,3
1Faculty of Engineering and IT, School of Biomedical Engineering, University of Technology Sydney, Ultimo, NSW, Australia.
Breast cancer research : BCR
|December 10, 2025
概括
选择正确的乳腺癌模型至关重要. 在小鼠体内注射更好地模仿早期瘤发育和转移,影响瘤进展和瘤微环境,以获得更好的治疗见解.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 使用4T1.2和67NR小鼠模型进行三阴性乳腺癌研究.
- 采用共生性,免疫能力的模型来研究癌症的进展.
研究的目的:
- 为了比较乳腺癌细胞植入的正管注射与导管内注射.
- 研究植入方法如何影响瘤进展,转移和瘤微环境.
主要方法:
- 对癌细胞植入路径的对智分析 (正极管与内导管).
- 使用了4T1.2 (转移性) 和67NR (非转移性) 鼠标模型.
- 在转移模型中用于免疫反应分析的单细胞RNA测序.
主要成果:
- 内导管内注射加速瘤生长,更好地模仿早期瘤发生.
- 植入方法会影响转移潜力和 stromal 的比例.
- 转移性4T1.2模型显示出明显的系统性炎症和骨髓质主导的免疫环境,与非转移性67NR不同.
结论:
- 实验模型的选择极大地影响了乳腺癌研究结果.
- 这些发现凸显了植入技术对于复制瘤进展和转移的重要性.
- 为开发免疫调节疗法提供了见解.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K


